Quick Read
- QBTS stock fell 21.44% in the last week of 2025, following a sharp rally driven by CES-related headlines.
- Insider activity has been dominated by selling, with D-Wave executives reducing their holdings significantly.
- Analysts remain bullish, issuing buy ratings and price targets ranging from $35 to $46, median at $37.5.
- Upcoming events (CES 2026, Qubits 2026) are viewed as key catalysts for sentiment and commercial traction.
- Institutional investors like Vanguard and UBS increased positions, while others trimmed holdings in Q3 2025.
As 2025 draws to a close, D-Wave Quantum Inc. (NYSE: QBTS) finds itself in the crosshairs of market volatility, insider activity, and heightened analyst attention. With U.S. markets closed for the weekend, investors are left to digest a rollercoaster week for one of quantum computing’s pure-play stocks. QBTS ended Friday at $25.29, down over 8%, and extended losses slightly in after-hours trading, according to Investing.com.
It’s a familiar pattern for QBTS traders: a dramatic surge—this time triggered by CES-related headlines—was quickly followed by aggressive profit-taking. The numbers speak for themselves. In just one week, the stock dropped 21.44%, wiping out gains from a 20% rally earlier in the week. On Dec. 22, QBTS closed at $32.19; by Dec. 26, it was at $25.29. Volume tapered off, amplifying the swings as fewer shares traded hands (MarketBeat).
The weekend analysis, with markets shut, leans into a tug-of-war of optimism and skepticism. MarketWatch divides quantum investors into three camps: pure plays like D-Wave, big tech platforms with quantum efforts, and infrastructure providers. Pure plays—D-Wave included—offer outsized potential, but carry significant risk. This “high-risk, high-upside” framing is echoed in analyst notes, where most firms maintain bullish ratings, but caution about valuation and commercialization hurdles.
On social media and forums, anticipation is building for D-Wave’s presence at CES 2026. The company plans a showcase of its commercial quantum solutions, hoping to stoke investor confidence and public interest. Yet, the conversation is far from one-sided. While many are hopeful D-Wave can deliver on its technological promises, skeptics point out the enormous challenges of scaling quantum computing in the real world.
Insider trading data paints a sobering picture. Over the past six months, D-Wave insiders have overwhelmingly sold shares—29 sales versus a single purchase. CEO Alan Baratz alone sold nearly 1.8 million shares for over $52 million. Other top executives, including the CFO and Chief Legal Officer, also reduced their stakes significantly (Quiver Quantitative). Such activity often raises questions about management’s confidence in near-term prospects.
Still, the fundamentals show progress. D-Wave reported Q3 2025 revenue of $3.7 million—doubling year-over-year—and bookings of $2.4 million, up 80% sequentially. The company boasted a record cash balance of $836 million, providing flexibility for ongoing investment. CEO Baratz described the quarter as reflecting “momentum building across every aspect” of the business (D-Wave Quantum IR).
Institutional investors have been actively repositioning. Giants like Vanguard, UBS, and BlackRock added millions of shares in Q3 2025, while others—Bank of America, Arrowstreet Capital, Marex Group—trimmed their holdings. This churn underscores the sector’s appeal to growth-focused funds, but also the wariness about its unpredictable trajectory.
Analyst sentiment, for now, remains upbeat. Nine firms issued buy ratings in recent months, and no firm has published a sell recommendation. Price targets cluster in the mid-$30s to mid-$40s, with Wedbush, Jefferies, and Mizuho all expecting significant upside. The median target sits at $37.50, while some outliers forecast as high as $50.40. Yet, bearish voices like Trefis warn of a possible retreat to $18, citing historical trading ranges and ongoing uncertainty.
October’s spike in QBTS stock—up 50% at one point—was fueled by a confluence of factors: JPMorgan Chase’s public commitment to quantum research (though not specifically naming D-Wave), a €10 million contract with Swiss Quantum Technology for European deployment, and a Fast Company award for D-Wave’s Advantage2 quantum computer. Rumors of U.S. government investment also swirled, but were denied by the Commerce Department (AOL, Reuters).
Looking ahead, investors are focused on several potential catalysts. D-Wave is set to sponsor the CES Foundry event in Las Vegas on Jan. 7–8, 2026, with a masterclass and demo by VP Murray Thom. Later in the month, the Qubits 2026 user conference in Florida will provide updates from executives, scientists, and customers—likely to generate headlines and impact sentiment.
Meanwhile, the formation of a U.S. Government Business Unit signals an effort to court federal contracts, particularly in national security and defense. Such partnerships could be transformative if commercial traction accelerates.
For retail and institutional investors, the coming weeks are pivotal. With earnings likely around mid-March (date unconfirmed), all eyes are on D-Wave’s ability to convert technical milestones into sustainable commercial growth. The stock’s 52-week range—$3.74 to $46.75—illustrates the dizzying swings that can occur when future-tech hopes meet the realities of execution.
As the U.S. market prepares to reopen on Monday, the central questions linger: Will dip-buyers step in after the latest slide, or will caution prevail as traders de-risk? CES 2026 and Qubits 2026 are looming as litmus tests for D-Wave’s commercial narrative. In quantum investing, the only certainty is uncertainty—and for QBTS, volatility remains the rule, not the exception.
Assessment: The facts show D-Wave Quantum at a crossroads—buoyed by strong analyst support and institutional interest, but shadowed by insider selling and commercialization risks. With near-term catalysts ahead, QBTS remains a high-stakes, high-volatility play where conviction can swing sharply on each new headline. Investors should approach with caution, treating bullish targets as guideposts and keeping a close eye on execution and real-world adoption.